Cargando…
Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case
Early access programs (EAPs) generally refer to patient access to medicines/indications before marketing authorization, possibly extended to price and reimbursement approval. These programs include compassionate use, which is usually covered by pharmaceutical companies, and EAPs reimbursed by third-...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193685/ https://www.ncbi.nlm.nih.gov/pubmed/37198599 http://dx.doi.org/10.1186/s40545-023-00570-z |